The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

NCT06655441 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Disease (DED)

Interventions

DRUG: 3% trehalose

Sponsor

Southern California College of Optometry at Marshall B. Ketchum University